Monoferric denied for missing prior authorization by Aetna?

Aetna's specific coverage criteria for monoferric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Requires Prior Authorization for Monoferric

Monoferric (ferric derisomaltose) is an intravenous iron infusion product. Aetna requires prior authorization (PA) for IV iron products because they represent a step up from oral supplementation, carry an infusion cost, and are subject to utilization management. A PA-required denial means a claim was submitted without the authorization, or the authorization request was denied. These are two different problems requiring different responses — confirm which applies before acting.

## Why This Is Resolvable or Appealable

If no PA was requested in advance, the path is to submit the authorization now (for future doses) and appeal the retroactive denial by documenting why the treatment was urgent or why the PA process could not be completed in advance. If the PA was submitted and denied, that denial is a standard adverse benefit determination subject to the full appeal process.

## Your Federal Appeal Rights

• Internal appeal (ERISA §503 / ACA §2719): A denied PA is an adverse benefit determination and triggers your right to a full-and-fair internal review. Deadlines are on the denial notice.
• External review (ACA §2719): After exhausting internal appeals, or if Aetna fails to act within statutory timeframes, you may request independent external review. The window is approximately 4 months from the final internal denial.
• Expedited review: If your condition is urgent, request expedited PA and, if denied, expedited appeal. Turnaround must be within 72 hours.

## Documentation to Gather

1. PA denial letter — the exact criteria Aetna used to deny the PA request. 2. Diagnosis and lab documentation — confirming the iron-deficiency anemia diagnosis and clinical basis for IV administration. 3. Prior oral iron trial record — dates, products tried, duration, and reason for discontinuation or inadequacy. 4. Prescriber medical-necessity letter — explaining why IV iron is required and why Monoferric is the selected agent. 5. Clinical urgency documentation — if the infusion was given without PA because delay posed a health risk, document that clinical urgency explicitly.

## Criteria-Mapping Structure

Download or request Aetna's current clinical policy for IV iron infusion. This document lists the specific criteria that must be met for PA approval. Work through each criterion one by one with your prescriber. For each criterion, identify the exact chart note, lab result, or clinical record that satisfies it and cite its date. A well-organized criteria map — criterion, chart source, date — submitted with your appeal significantly increases approval rates compared to a narrative letter alone.